Involvement of ERK 1/2 activation in electroacupuncture pretreatment via cannabinoid CB1 receptor in rats

Brain Research

Volumn 1360, Issue , 2010, Pages 1-7

  Du, Juan ^a   Wang, Qiang ^a   Hu, Bo ^a   Peng, Zhengwu ^b   Zhao, Yu ^a   Ma, Lei ^a   Xiong, Lize ^a   Lu, Yan ^a   Zhu, Xiaoling ^a   Chen, Shaoyang ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

CB1 receptor; Electroacupuncture; ERK1 2; Ischemic tolerance; Pretreatment

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; CANNABINOID 1 RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION SIZE; BRAIN PROTECTION; CONTROLLED STUDY; ELECTROACUPUNCTURE; ENZYME ACTIVATION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROLOGIC EXAMINATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION; SCORING SYSTEM; TRANSIENT ISCHEMIC ATTACK; UPREGULATION;

ANIMALS; BEHAVIOR, ANIMAL; BLOTTING, WESTERN; BRAIN ISCHEMIA; BUTADIENES; ELECTROACUPUNCTURE; ENZYME ACTIVATION; ENZYME INHIBITORS; INFARCTION, MIDDLE CEREBRAL ARTERY; ISCHEMIC ATTACK, TRANSIENT; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEUROPROTECTIVE AGENTS; NITRILES; PIPERIDINES; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB1; REPERFUSION INJURY; SIGNAL TRANSDUCTION; UP-REGULATION;

RATTUS;

EID: 77957967784     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2010.07.034     Document Type: Article

References (32)

1. T. Aguado, E. Romero, K. Monory, J. Palazuelos, M. Sendtner, G. Marsicano, B. Lutz, M. Guzman, and I. Galve-Roperh The CB1 cannabinoid receptor mediates excitotoxicity-induced neural progenitor proliferation and neurogenesis J. Biol. Chem. 282 2007 23892 23898
2. J.L. Cadet, and I.N. Krasnova Cellular and molecular neurobiology of brain preconditioning Mol. Neurobiol. 39 2009 50 61
3. J.S. Choi, H.Y. Kim, J.H. Cha, and M.Y. Lee Ischemic preconditioning- induced activation of ERK1/2 in the rat hippocampus Neurosci. Lett. 409 2006 187 191
4. A.G. Corbille, E. Valjent, G. Marsicano, C. Ledent, B. Lutz, D. Herve, and J.A. Girault Role of cannabinoid type 1 receptors in locomotor activity and striatal signaling in response to psychostimulants J. Neurosci. 27 2007 6937 6947
5. P. Derkinderen, E. Valjent, M. Toutant, J.C. Corvol, H. Enslen, C. Ledent, J. Trzaskos, J. Caboche, and J.A. Girault Regulation of extracellular signal-regulated kinase by cannabinoids in hippocampus J. Neurosci. 23 2003 2371 2382
6. U. Dirnagl, K. Becker, and A. Meisel Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use Lancet Neurol. 8 2009 398 412
7. H. Dong, Y.H. Fan, W. Zhang, Q. Wang, Q.Z. Yang, and L.Z. Xiong Repeated electroacupuncture preconditioning attenuates matrix metalloproteinase-9 expression and activity after focal cerebral ischemia in rats Neurol. Res. 31 2009 853 858
8. J.H. Garcia, S. Wagner, K.F. Liu, and X.J. Hu Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation Stroke 26 1995 627 634 discussion 635
9. M. Guzman, C. Sanchez, and I. Galve-Roperh Control of the cell survival/death decision by cannabinoids J. Mol. Med. 78 2001 613 625
10. D.J. Hausenloy, M.M. Mocanu, and D.M. Yellon Cross-talk between the survival kinases during early reperfusion: its contribution to ischemic preconditioning Cardiovasc. Res. 63 2004 305 312
11. C.J. Hillard Role of cannabinoids and endocannabinoids in cerebral ischemia Curr. Pharm. Des. 14 2008 2347 2361
12. A.F. Hoffman, M. Oz, R. Yang, A.H. Lichtman, and C.R. Lupica Opposing actions of chronic Delta9-tetrahydrocannabinol and cannabinoid antagonists on hippocampal long-term potentiation Learn. Mem. 14 2007 63 74
13. D.A. Karanian, Q.B. Brown, A. Makriyannis, and B.A. Bahr Blocking cannabinoid activation of FAK and ERK1/2 compromises synaptic integrity in hippocampus Eur. J. Pharmacol. 508 2005 47 56
14. A. Korzh, O. Keren, M. Gafni, H. Bar-Josef, and Y. Sarne Modulation of extracellular signal-regulated kinase (ERK) by opioid and cannabinoid receptors that are expressed in the same cell Brain Res. 1189 2008 23 32
15. T. Mori, X. Wang, J.C. Jung, T. Sumii, A.B. Singhal, M.E. Fini, C.E. Dixon, A. Alessandrini, and E.H. Lo Mitogen-activated protein kinase inhibition in traumatic brain injury: in vitro and in vivo effects J. Cereb. Blood Flow Metab. 22 2002 444 452
16. S. Muthian, D.J. Rademacher, C.T. Roelke, G.J. Gross, and C.J. Hillard Anandamide content is increased and CB1 cannabinoid receptor blockade is protective during transient, focal cerebral ischemia Neuroscience 129 2004 743 750
17. S. Namura, K. Iihara, S. Takami, I. Nagata, H. Kikuchi, K. Matsushita, M.A. Moskowitz, J.V. Bonventre, and A. Alessandrini Intravenous administration of MEK inhibitor U0126 affords brain protection against forebrain ischemia and focal cerebral ischemia Proc. Natl. Acad. Sci. U. S. A. 98 2001 11569 11574
18. D. Panikashvili, R. Mechoulam, S.M. Beni, A. Alexandrovich, and E. Shohami CB1 cannabinoid receptors are involved in neuroprotection via NF-kappa B inhibition J. Cereb. Blood Flow Metab. 25 2005 477 484
19. R.G. Pertwee Inverse agonism and neutral antagonism at cannabinoid CB1 receptors Life Sci. 76 2005 1307 1324
20. T. Rubino, M. Sala, D. Vigano, D. Braida, C. Castiglioni, V. Limonta, C. Guidali, N. Realini, and D. Parolaro Cellular mechanisms underlying the anxiolytic effect of low doses of peripheral Delta9-tetrahydrocannabinol in rats Neuropsychopharmacology 32 2007 2036 2045
21. M. Shamloo, A. Rytter, and T. Wieloch Activation of the extracellular signal-regulated protein kinase cascade in the hippocampal CA1 region in a rat model of global cerebral ischemic preconditioning Neuroscience 93 1999 81 88
22. L. Sironi, C. Banfi, M. Brioschi, P. Gelosa, U. Guerrini, E. Nobili, A. Gianella, R. Paoletti, E. Tremoli, and M. Cimino Activation of NF-kB and ERK1/2 after permanent focal ischemia is abolished by simvastatin treatment Neurobiol. Dis. 22 2006 445 451
23. C. Strohm, T. Barancik, M.L. Bruhl, S.A. Kilian, and W. Schaper Inhibition of the ER-kinase cascade by PD98059 and UO126 counteracts ischemic preconditioning in pig myocardium J. Cardiovasc. Pharmacol. 36 2000 218 229
24. M. van der Stelt, and V. Di Marzo Cannabinoid receptors and their role in neuroprotection Neuromolecular Med. 7 2005 37 50
25. Z.Q. Wang, D.C. Wu, F.P. Huang, and G.Y. Yang Inhibition of MEK/ERK 1/2 pathway reduces pro-inflammatory cytokine interleukin-1 expression in focal cerebral ischemia Brain Res. 996 2004 55 66
26. Q. Wang, L. Xiong, S. Chen, Y. Liu, and X. Zhu Rapid tolerance to focal cerebral ischemia in rats is induced by preconditioning with electroacupuncture: window of protection and the role of adenosine Neurosci. Lett. 381 2005 158 162
27. Q. Wang, X. Gou, L. Xiong, W. Jin, S. Chen, L. Hou, and L. Xu Trans-activator of transcription-mediated delivery of NEP1-40 protein into brain has a neuroprotective effect against focal cerebral ischemic injury via inhibition of neuronal apoptosis Anesthesiology 108 2008 1071 1080
28. Q. Wang, Y. Peng, S. Chen, X. Gou, B. Hu, J. Du, Y. Lu, and L. Xiong Pretreatment with electroacupuncture induces rapid tolerance to focal cerebral ischemia through regulation of endocannabinoid system Stroke 40 2009 2157 2164
29. L. Xiong, Z. Lu, L. Hou, H. Zheng, Z. Zhu, Q. Wang, and S. Chen Pretreatment with repeated electroacupuncture attenuates transient focal cerebral ischemic injury in rats Chin. Med. J. (Engl.) 116 2003 108 111
30. L.Z. Xiong, J. Yang, Q. Wang, and Z.H. Lu Involvement of delta- and mu-opioid receptors in the delayed cerebral ischemic tolerance induced by repeated electroacupuncture preconditioning in rats Chin. Med. J. (Engl.) 120 2007 394 399
31. M. Zhang, B.R. Martin, M.W. Adler, R.K. Razdan, D. Ganea, and R.F. Tuma Modulation of the balance between cannabinoid CB(1) and CB(2) receptor activation during cerebral ischemic/reperfusion injury Neuroscience 152 2008 753 760
32. Z. Zuo, Y. Wang, and Y. Huang Isoflurane preconditioning protects human neuroblastoma SH-SY5Y cells against in vitro simulated ischemia-reperfusion through the activation of extracellular signal-regulated kinases pathway Eur. J. Pharmacol. 542 2006 84 91